Spectrum Pharma (SPPI) Tops Q3 EPS by 5c

Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.56 million versus the consensus estimate of $24.93 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Movano (MOVE) Misses Q2 EPS by 195c